Data as of Apr 17
| +0.55 / +1.53%|
The 13 analysts offering 12-month price forecasts for DexCom Inc have a median target of 47.00, with a high estimate of 51.00 and a low estimate of 27.75. The median estimate represents a +28.49% increase from the last price of 36.58.
The current consensus among 14 polled investment analysts is to Buy stock in DexCom Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.